36
Participants
Start Date
June 21, 2021
Primary Completion Date
March 1, 2023
Study Completion Date
July 20, 2023
Linezolid
"Overall, there is an urgent need for improvement of TBM treatment. LInezolid is known to be well-penetrated to blood brain barrier. A combination of high-dose rifampicin and linezolid as an intensified add-on therapy in the management of TB meningitis has never been studied.~The goal is to assess the most appropriate dose of linezolid for larger follow-up studies and to evaluate the feasibility of a linezolid-containing TBM regimen."
Hasan Sadikin General Hospital, Bandung
Radboud University Medical Center
OTHER
Global Alliance for TB Drug Development
OTHER
Universitas Padjadjaran
OTHER